Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs Simvastatin in Type 2 Diabetic Subjects with Hypercholesterolemia
NCT00141141Phase 4Completed
- Sponsor
- Viatris
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atorvastatin in hypercholesterolemia (2 arms), sponsored by Viatris. Primary endpoint: Decrease of LDL-C at 24 weeks. Started Jan 2004; status: completed.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00141141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141141.